Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use CUROSURF® safely and effectively. See full prescribing information for CUROSURF. CUROSURF (poractant alfa) intratracheal suspension Initial U.S. Approval: 1999
Medication labelWhy this: Advisory · dailymed-prescription
CUROSURF® (poractant alfa) Intratracheal Suspension is indicated for the rescue treatment of Respiratory Distress Syndrome (RDS) in premature infants. CUROSURF reduces mortality and pneumothoraces associated with RDS.
- generic_name
- poractant alfa
- product_names
- poractant alfa
- ndc
- 10122-510, 10122-510-03, 10122-510-01
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en